Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.

Therapeutics

Life Sciences

Biotechnology

Nexo Therapeutics

Andrew Phillips

Rhamy Zeid

Joe Patel

Michael Kim

Research and Chemistry Team

Leadership Team

��

Teams at Nexo Therapeutics

Research and Chemistry Team

Leadership Team

��������

Teams at Nexo Therapeutics

Research and Chemistry Team

Leadership Team

��